Published in AIDS Res Hum Retroviruses on June 01, 2008
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One (2009) 8.37
Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa. AIDS Res Hum Retroviruses (2010) 2.05
HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high. PLoS One (2011) 1.45
Reverse transcriptase inhibitors as potential colorectal microbicides. Antimicrob Agents Chemother (2009) 1.26
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med (2008) 1.23
Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya. AIDS Res Hum Retroviruses (2012) 0.93
Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria. AIDS Res Hum Retroviruses (2013) 0.91
Transmitted drug resistance in nonsubtype B HIV-1 infection. HIV Ther (2009) 0.90
Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria. Am J Trop Med Hyg (2011) 0.90
The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention. Infect Disord Drug Targets (2011) 0.84
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda. PLoS One (2015) 0.81
The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'. Trop Med Int Health (2014) 0.79
Impact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomes. Viruses (2014) 0.79
Genetic Diversity and Drug Resistance Mutations in HIV-1 from Untreated Patients in Niamey, Niger. ISRN Microbiol (2011) 0.75
Low prevalence of the transmitted HIV-1 drug resistance among newly diagnosed HIV-1 individuals in Jiangsu Province, China during 2009-2011. BMC Public Health (2015) 0.75
Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya. PLoS One (2017) 0.75
Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT. PLoS One (2017) 0.75
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet (1998) 3.22
The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS (1992) 2.70
Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44
Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis (1999) 2.37
Community engagement in health research: two decades of experience from a research project on HIV in rural Uganda. Trop Med Int Health (2009) 2.33
Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull World Health Organ (1995) 2.29
Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania. Sex Transm Infect (2003) 2.14
Sexual behaviour patterns and other risk factors for HIV infection in rural Tanzania: a case-control study. AIDS (1997) 2.05
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis (2005) 1.95
Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Trop Med Int Health (2009) 1.79
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Rationale and design of the MEMA kwa Vijana adolescent sexual and reproductive health intervention in Mwanza Region, Tanzania. AIDS Care (2006) 1.62
Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization. J Virol (1996) 1.59
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol (2010) 1.58
Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis (1996) 1.53
Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS (2000) 1.50
'What if they ask how I got it?' Dilemmas of disclosing parental HIV status and testing children for HIV in Uganda. Health Policy Plan (2008) 1.50
A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour. Genitourin Med (1993) 1.42
Is sexual risk taking behaviour changing in rural south-west Uganda? Behaviour trends in a rural population cohort 1993-2006. Sex Transm Infect (2009) 1.42
Risk factors for active syphilis and TPHA seroconversion in a rural African population. Sex Transm Infect (2001) 1.42
HIV-associated adult mortality in a rural Tanzanian population. AIDS (1997) 1.40
A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 1. Prevalence and incidence. Genitourin Med (1993) 1.39
Interpretation of the Mwanza and Rakai STD trials. Bull World Health Organ (2001) 1.38
The value of urine specimens in screening for male urethritis and its microbial aetiologies in Tanzania. Genitourin Med (1992) 1.36
Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS (1998) 1.35
Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer (1996) 1.34
Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer (1975) 1.29
Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect (1998) 1.29
Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS (2001) 1.29
The sexual health of pupils in years 4 to 6 of primary schools in rural Tanzania. Sex Transm Infect (2004) 1.27
A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design. AIDS (1995) 1.26
Sentinel surveillance for HIV-1 among pregnant women in a developing country: 3 years' experience and comparison with a population serosurvey. AIDS (1993) 1.24
The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect (2001) 1.24
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.21
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21
Helminths and HIV infection: epidemiological observations on immunological hypotheses. Parasite Immunol (2006) 1.21
Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors. Sex Transm Infect (2003) 1.21
The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis (1999) 1.20
Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA (1994) 1.19
Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS (1994) 1.18
Validation of a WHO algorithm with risk assessment for the clinical management of vaginal discharge in Mwanza, Tanzania. Sex Transm Infect (1998) 1.17
Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect (2006) 1.15
Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa? Trop Med Int Health (2010) 1.14
Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer (2004) 1.14
Antimicrobial susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high level plasmid mediated tetracycline resistance. Genitourin Med (1995) 1.12
High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study. Sex Transm Infect (2000) 1.12
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis (2003) 1.11
How many patients with a sexually transmitted infection are cured by health services? A study from Mwanza region, Tanzania. Trop Med Int Health (2001) 1.11
Prevalence of HIV and Chlamydia trachomatis infection in 15--19-year olds in rural Tanzania. Trop Med Int Health (2001) 1.11
The experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care (2010) 1.07
Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm Dis (1997) 1.06
Long-term experience with Burkitt's lymphoma in Uganda. Int J Cancer (1980) 1.03
Patterns of sexual behaviour in a rural population in north-western Tanzania. Soc Sci Med (1997) 1.01
STD research in Africa. Lancet (1993) 1.01
Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene. J Gen Virol (2001) 1.01
Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda. HIV Med (2011) 1.00
Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy. Trop Med Int Health (2010) 0.99
Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients. AIDS (2001) 0.98
Adolescent reproductive health and awareness of HIV among rural high school students, North Western Ethiopia. AIDS Care (2004) 0.98
An African perspective on mucosal immunity and HIV-1. Mucosal Immunol (2009) 0.97
Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania. AIDS (2000) 0.97
Molecular epidemiology of HIV-1 in the former Soviet Union: analysis of env V3 sequences and their correlation with epidemiologic data. AIDS (1994) 0.96
Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1-infected Ugandan adults. Trop Med Int Health (2010) 0.95
Childhood Hodgkin's disease in Uganda: a ten year experience. Cancer (1978) 0.91
STD rapid assessment in Rwandan refugee camps in Tanzania. Genitourin Med (1997) 0.90
beta-2 Microglobulin values among human immunodeficiency virus (HIV)-negative, HIV-positive asymptomatic, and HIV-positive symptomatic Ugandans. Clin Diagn Lab Immunol (1995) 0.90
Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses (2000) 0.90
Tat-specific binding IgG and disease progression in HIV type 1-infected Ugandans. AIDS Res Hum Retroviruses (2008) 0.88
HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis. AIDS (2001) 0.87
Geographic diversity of human immunodeficiency virus type 1: serologic reactivity to env epitopes and relationship to neutralization. J Infect Dis (1992) 0.85
Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer (1980) 0.85
Diminished delayed hypersensitivity responses in the legs and feet of patients with endemic Kaposi's sarcoma. Trans R Soc Trop Med Hyg (1996) 0.85
AIDS in Africa: problems for research and researchers. Lancet (1990) 0.85
Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay. Clin Diagn Lab Immunol (1996) 0.84
Residual activity of two HIV antiretroviral regimens prescribed without virological monitoring. Antimicrob Agents Chemother (2011) 0.84
The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda. Int J STD AIDS (2001) 0.83
Activation by malaria antigens renders mononuclear cells susceptible to HIV infection and re-activates replication of endogenous HIV in cells from HIV-infected adults. Parasite Immunol (2004) 0.83
Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy. Int J Cancer (1976) 0.83
Effectiveness, impact and cost of syndromic management of sexually transmitted diseases in Tanzania. Int J STD AIDS (1998) 0.83
The structure of the O-specific polysaccharide chain of the lipopolysaccharide of Salmonella arizonae O61. Carbohydr Res (1992) 0.82
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg (1991) 0.82
Human immunodeficiency virus (HIV) in developing countries. Ann Trop Med Parasitol (2006) 0.82
Kaposi's sarcoma: recent developments. AIDS (1991) 0.81
Absence of sex-hormone receptors in Kaposi's sarcoma. Lancet (1995) 0.80
The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'. Trop Med Int Health (2014) 0.79
Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in Uganda. Int J STD AIDS (2007) 0.79